Advertisement
Advertisement
U.S. Markets open in 8 hrs 55 mins
Advertisement
Advertisement
Advertisement
Advertisement

Stoke Therapeutics, Inc. (STOK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
8.30+0.13 (+1.59%)
At close: 04:00PM EDT
8.39 +0.09 (+1.08%)
After hours: 06:02PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/22/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.40
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 324.97
52 Week Low 36.88
50-Day Moving Average 39.17
200-Day Moving Average 312.01

Share Statistics

Avg Vol (3 month) 3333.47k
Avg Vol (10 day) 3424.37k
Shares Outstanding 539.43M
Implied Shares Outstanding 6N/A
Float 814.72M
% Held by Insiders 16.25%
% Held by Institutions 1116.02%
Shares Short (Jan 30, 2023) 43.82M
Short Ratio (Jan 30, 2023) 412.76
Short % of Float (Jan 30, 2023) 416.94%
Short % of Shares Outstanding (Jan 30, 2023) 49.69%
Shares Short (prior month Dec 29, 2022) 43.84M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sep 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,113.12%

Management Effectiveness

Return on Assets (ttm)-23.92%
Return on Equity (ttm)-45.22%

Income Statement

Revenue (ttm)9.14M
Revenue Per Share (ttm)0.24
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -100.53M
Net Income Avi to Common (ttm)-99.86M
Diluted EPS (ttm)-2.09
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)251.66M
Total Cash Per Share (mrq)6.38
Total Debt (mrq)5.63M
Total Debt/Equity (mrq)2.76
Current Ratio (mrq)9.19
Book Value Per Share (mrq)6.46

Cash Flow Statement

Operating Cash Flow (ttm)-25.75M
Levered Free Cash Flow (ttm)-32.45M
Advertisement
Advertisement